A Phase 1 First in Human Open-Label Study of the Safety and Pharmacokinetics of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Zolmitriptan (Primary) ; Zolmitriptan; Zolmitriptan
- Indications Migraine
- Focus Adverse reactions; First in man; Pharmacokinetics; Therapeutic Use
- Sponsors Acorda Therapeutics
- 09 Jun 2016 According to an Acorda Therapeutics media release, results (n=21) of this trial were presented at the 58th Annual Scientific Meeting of the American Headache Society, 2016.
- 09 Jun 2016 Results (n=21) published in an Acorda Therapeutics media release.
- 03 Jun 2016 Status changed from active, no longer recruiting to completed.